# CHINOOK THERAPEUTICS, INC.

CHINOOK THERAPEUTICS, INC. is a company headquartered in Seattle, WA, United States.

## Company overview

- **Legal name:** CHINOOK THERAPEUTICS, INC.
- **Former names in filing history:** ADURO BIOTECH, INC. (2011-12-05 to 2020-10-15); ADURO BIOTECH (2008-05-08 to 2011-04-22)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Seattle, WA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001435049

## About

CHINOOK THERAPEUTICS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001435049, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-02-27, it reported annual revenue of USD 6,128,000; net income of USD -187,865,000; total assets of USD 574,084,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $6.1M (USD 6,128,000)
- **Net income:** -$187.9M (USD -187,865,000)
- **Total assets:** $574.1M (USD 574,084,000)
- **Cash and equivalents:** $115.4M (USD 115,438,000)
- **Operating cash flow:** -$117.5M (USD -117,481,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $51.6M (USD 51,625,000)
- **Net income:** -$102.9M (USD -102,937,000)
- **Total assets:** $563.8M (USD 563,803,000)
- **Cash and equivalents:** $181.7M (USD 181,724,000)
- **Operating cash flow:** -$102.7M (USD -102,744,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $827,000 (USD 827,000)
- **Net income:** -$81.6M (USD -81,622,000)
- **Total assets:** $429.0M (USD 429,002,000)
- **Cash and equivalents:** $187.8M (USD 187,750,000)
- **Operating cash flow:** -$55.8M (USD -55,848,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $17.3M (USD 17,258,000)
- **Net income:** -$82.4M (USD -82,372,000)
- **Total assets:** $291.3M (USD 291,313,000)
- **Cash and equivalents:** $59.6M (USD 59,624,000)
- **Operating cash flow:** -$65.5M (USD -65,508,000)
- **Later filings:** Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form SC 13D — filed 2023-08-11
- Form 8-K — filed 2023-08-11 — period 2023-08-11 — 8-K
- Form 10-Q — filed 2023-08-07 — period 2023-06-30 — 10-Q
- Form 8-K — filed 2023-08-03 — period 2023-08-02 — 8-K
- Form 8-K — filed 2023-07-28 — period 2023-07-28 — 8-K
- Form 8-K — filed 2023-06-20 — period 2023-06-17 — 8-K
- Form 8-K — filed 2023-06-15 — period 2023-06-09 — 8-K
- Form 8-K — filed 2023-06-12 — period 2023-06-12 — 8-K
- Form 8-K — filed 2023-06-12 — period 2023-06-11 — 8-K
- Form 10-Q — filed 2023-05-09 — period 2023-03-31 — 10-Q
- Form 8-K — filed 2023-05-09 — period 2023-05-09 — 8-K
- Form DEF 14A — filed 2023-04-28 — period 2023-06-09 — DEF 14A

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/chinook-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology